NCT00677105 2012-09-17A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1 Completed92 enrolled